- Lobbying
- Lobbying by ENDO PHARMACEUTICALS
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Kathryn Marks | Legislative Assistant, Senator John Edwards |
Tim Trysla | Sr. Pol. Adv., CMS; Off. of Rep. Bill Archer Soc. Sec. Advisory Coun., Steelman Commission |
Regina Sherick | Staff Assistant, Senate Finance Committee |
Colin Roskey | Republican Staff, Senate Finance Committee |
Kim Brandt | Technical Advisor to CFO, CMS Senior Counsel, Office of Inspector General Legislative Assistant, Rep. Paul Gillmor |
Mark Rayder | n/a |
Jennifer Butler | n/a |
Rudy Missmar | n/a |
Keavney Klein | n/a |
Kimberly Brandt | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
MM Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues related to Medicare Modernization Act of 2003 (P.L. 108-173) and general health and regulatory work and advice..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate